‘Life-saving’ breast cancer drug Olaparib accepted for NHS use in Scotland by Scottish Medicines Consortium

[#item_full_content]

​Olaparib targets hereditary BRCA gene mutations in early breast cancer previously treated with chemotherapy. Olaparib targets hereditary BRCA gene mutations in early breast cancer previously treated with chemotherapy.